Xeomin 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26F7MGS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,730
Award facts
- Contract value 100% obligated
- $24,730.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $24.7K to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials on November 25, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 17, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Xeomin is a botulinum toxin product used in medical and therapeutic applications, and this delivery order fulfills federal pharmaceutical procurement needs through the DLA Medical Supply Chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contract awards covering diverse therapeutic domains including specialty medications, vaccines, and medical supplies. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its significant prime vendor status, positions it as a critical supplier for Defense Health Agency and other federal healthcare systems requiring reliable access to specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26F7MGS?
SPE2DR26F7MGS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F7MGS worth?
The government has obligated $24,730 on SPE2DR26F7MGS.
Is contract SPE2DR26F7MGS an order under another contract?
Yes. SPE2DR26F7MGS is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MGS competed?
The extent of competition for SPE2DR26F7MGS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award